Search Results

An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...

Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...

Read key findings from the 2020 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Unlike other NSDUH Annual National Reports, the 2020 report has no comparisons...

P-value tables to compare substate estimates within and across states for 2018-2019.

These state profiles include data from facilities that reported to N-SSATS for the survey reference date March 29, 2019. The N-SSATS collects data on the location, characteristics, services offered, and number of clients (collected every other year) in treatment at alcohol and drug abuse treatment facilities (public and private) throughout...

Read key findings from the 2019 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. The report covers both current conditions and trends over time.
Along with...

Get detailed national estimates from the 2018 and 2019 National Surveys on Drug Use and Health (NSDUH). The tables provide comprehensive statistics on substance use, mental health, and treatment in the United States. Longer-term trends are also available for select indicators.

The tables are based on the NSDUH survey, which...

National maps showing 2016-2018 estimates for the substate regions ranked from lowest to highest for each measure and divided into 7 categories.

Prevalence estimates for 15 measures of substance use and mental illness are provided along with 95% confidence intervals for persons aged 12 or older for the substance use measures, persons aged 18 or older for the mental illness measures, and persons aged 12-20 for one alcohol measure.

Tables of prevalence estimates for persons aged 12 to 17, 18 to 25, 26 or older, and aged 18 or older.

Tables and maps defining the substate regions for each state and the District of Columbia.

Tables showing the 2014-2016 and 2016-2018 substate area estimates and the percent Bayesian confidence intervals along with an indication of statistical significance of the difference.

P-value tables to compare substate estimates within and across states for 2016-2018.

This report provides a guide to the development and presentation of 2016-2018 NSDUH substate estimates. A summary of the estimation methodology is included as well as sample sizes, response rates, and population estimates. This shapefile includes geographic boundaries of the 2016-2018 NSDUH substate regions along with prevalence rates, map group...